Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
Launched by UNIVERSITY OF CALGARY · Apr 28, 2025
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The EXCEL Exercise Oncology Program is a clinical trial aimed at helping people living with cancer, including prostate, breast, colon, and lung cancers, to incorporate exercise into their daily lives. This program offers both online and in-person exercise classes designed to be safe and manageable for individuals with a cancer diagnosis. The goal is to improve physical fitness and overall well-being during and after cancer treatment. Researchers will evaluate how effective this community-based program is in making exercise more accessible and appealing to cancer survivors across Canada.
To participate in the trial, individuals must be at least 18 years old and have a history of cancer. This includes those currently receiving treatment or those who have completed treatment within the past three years. Participants should be capable of engaging in low-intensity exercise, and they must be able to provide consent in English or French. The program lasts for 8 to 12 weeks and involves attending exercise classes twice a week, either in person or online. It’s a great opportunity for anyone looking to improve their fitness and health while connecting with others who understand the challenges of living with cancer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • have or had a diagnosis of cancer;
- • be 18 years or older;
- • be able to participate in low-intensity levels of activity, at minimum;
- • be pretreatment, or receiving active cancer treatment (i.e., surgery, systemic therapy and radiation therapy), have received cancer treatment within the past 3 years, or if beyond 3 years since treatment completion, have a referral from their healthcare team indicating they have side effects from cancer treatment or the cancer itself, that could be improved or managed with exercise;
- • be able to provide informed written consent in English or French
- Exclusion Criteria:
- • does not or did not have a cancer diagnosis
- • is under the age of 18
- • is unable to participate in mild exercise, at minimum
- • is not pretreatment, or receiving active cancer treatment (i.e., surgery, systemic therapy and radiation therapy), has not received cancer treatment within the past 3 years, or if beyond 3 years since treatment completion, doesn't have side effects from cancer treatment or the cancer itself, that could be improved or managed with exercise
- • unable to read/write in English
- • for online programs, does not have internet or computer access
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Calgary, Alberta, Canada
Montreal, Quebec, Canada
Vancouver, British Columbia, Canada
Halifax, Nova Scotia, Canada
Patients applied
Trial Officials
Nicole Culos-Reed, PhD
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported